Cargando…

Effects of Alkaline-Reduced Drinking Water on Irritable Bowel Syndrome with Diarrhea: A Randomized Double-Blind, Placebo-Controlled Pilot Study

OBJECTIVES: The purpose of this study was to investigate whether the ingestion of alkaline-reduced water (ARW) is helpful in improving the symptoms of diarrhea-predominant irritable bowel syndrome (IBS). METHODS: Twenty-seven patients (male, 25.9%; mean, 41.7 years old) with diarrhea-predominant IBS...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shin, Dong Woo, Yoon, Hyuk, Kim, Hyun Soo, Choi, Yoon Jin, Shin, Cheol Min, Park, Young Soo, Kim, Nayoung, Lee, Dong Ho
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5925025/ https://www.ncbi.nlm.nih.gov/pubmed/29849734 http://dx.doi.org/10.1155/2018/9147914

Ejemplares similares

Effect of administering a multi-species probiotic mixture on the changes in fecal microbiota and symptoms of irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial
por: Yoon, Hyuk, et al.
Publicado: (2015)

A Randomized, Double-blinded, Placebo-controlled Study to Evaluate the Efficacy and Safety of DA-9701 (Motilitone) in Patients With Constipation-type Irritable Bowel Syndrome and Functional Dyspepsia Overlap: A Pilot Study
por: Lee, Ju Yup, et al.
Publicado: (2022)

Efficacy of DA-5204 (Stillen 2X) for patients with gastroesophageal reflux disease: A randomized, double-blind, placebo-controlled pilot study
por: Cho, Jae Ho, et al.
Publicado: (2020)

The Effect of Phloroglucinol in Patients With Diarrhea-predominant Irritable Bowel Syndrome: A Randomized, Double-blind, Placebo-controlled Trial
por: Shin, Seung Yong, et al.
Publicado: (2020)

A double blind, placebo-controlled, randomized clinical trial that breast milk derived-Lactobacillus gasseri BNR17 mitigated diarrhea-dominant irritable bowel syndrome
por: Shin, Suk Pyo, et al.
Publicado: (2018)

Compositional and Functional Changes in the Gut Microbiota in Irritable Bowel Syndrome Patients
por: Lee, Sun Min, et al.
Publicado: (2021)

Sex difference in bowel preparation quality and colonoscopy time
por: Hwang, Young-Jae, et al.
Publicado: (2021)

A randomized, double-blind, placebo-controlled study to assess efficacy of mirtazapine for the treatment of diarrhea predominant irritable bowel syndrome
por: Khalilian, Alireza, et al.
Publicado: (2021)

The relationship between drinking alcohol and esophageal, gastric or colorectal cancer: A nationwide population-based cohort study of South Korea
por: Choi, Yoon Jin, et al.
Publicado: (2017)

Higher levels of disease-related knowledge reduce medical acceleration in patients with inflammatory bowel disease
por: Park, Jihye, et al.
Publicado: (2020)

Correction: The relationship between drinking alcohol and esophageal, gastric or colorectal cancer: A nationwide population-based cohort study of South Korea
por: Choi, Yoon Jin, et al.
Publicado: (2018)

Clinical factors to predict flare-up in patients with inflammatory bowel disease during international air travel: A prospective study
por: Park, Jihye, et al.
Publicado: (2022)

Trends in emergency department visits and hospitalization rates for inflammatory bowel disease in the era of biologics
por: Huh, Gunn, et al.
Publicado: (2019)

Distribution of small bowel involvement and its association with clinical outcomes in patients with Crohn’s disease
por: Park, Jin, et al.
Publicado: (2023)

Effect of Korean Herbal Medicine Combined with a Probiotic Mixture on Diarrhea-Dominant Irritable Bowel Syndrome: A Double-Blind, Randomized, Placebo-Controlled Trial
por: Ko, Seok-Jae, et al.
Publicado: (2013)

Bacillus coagulans MTCC 5856 supplementation in the management of diarrhea predominant Irritable Bowel Syndrome: a double blind randomized placebo controlled pilot clinical study
por: Majeed, Muhammed, et al.
Publicado: (2016)

Correction: Trends in emergency department visits and hospitalization rates for inflammatory bowel disease in the era of biologics
por: Huh, Gunn, et al.
Publicado: (2019)

The effect of vitamin D administration on inflammatory markers in patients with inflammatory bowel disease
por: Jun, Jae Chang, et al.
Publicado: (2019)

Kimchi improves irritable bowel syndrome: results of a randomized, double-blind placebo-controlled study
por: Kim, Hee-Young, et al.
Publicado: (2022)

Efficacy of Chinese Herbal Medicine for Diarrhea-Predominant Irritable Bowel Syndrome: A Meta-Analysis of Randomized, Double-Blind, Placebo-Controlled Trials
por: Zhu, Jia-Jie, et al.
Publicado: (2016)

The effect of Clostridium butyricum on symptoms and fecal microbiota in diarrhea-dominant irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial
por: Sun, Yi-Yuan, et al.
Publicado: (2018)

Potential of Gut Microbe-Derived Extracellular Vesicles to Differentiate Inflammatory Bowel Disease Patients from Healthy Controls
por: Heo, Min, et al.
Publicado: (2023)

Evaluation of the irritable bowel syndrome severity index in Japanese male patients with irritable bowel syndrome with diarrhea
por: Ida, Motoko, et al.
Publicado: (2017)

The Efficacy of Shugan Jianpi Zhixie Therapy for Diarrhea-Predominant Irritable Bowel Syndrome: A Meta-Analysis of Randomized, Double-Blind, Placebo-Controlled Trials
por: Xiao, Ya, et al.
Publicado: (2015)

Effect of Oral Intake of Lactiplantibacillus plantarum APsulloc 331261 (GTB1(TM)) on Diarrhea-Predominant Irritable Bowel Syndrome: A Randomized, Double-Blind, Placebo-Controlled Study
por: Jung, Kyoungmi, et al.
Publicado: (2022)

Risk Factors for Vitamin D, Zinc, and Selenium Deficiencies in Korean Patients with Inflammatory Bowel Disease
por: Han, Yoo Min, et al.
Publicado: (2017)

The efficacy of Bifidobacterium quadruple viable tablet in the treatment of diarrhea predominant irritable bowel syndrome: protocol for a randomized, double-blind, placebo-controlled, multicenter trial
por: Bai, Tao, et al.
Publicado: (2020)

Efficacy and Safety of New Lactobacilli Probiotics for Unconstipated Irritable Bowel Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial
por: Oh, Joo Hyun, et al.
Publicado: (2019)

Efficacy of a Synbiotic Containing Lactobacillus paracasei DKGF1 and Opuntia humifusa in Elderly Patients with Irritable Bowel Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial
por: Oh, Joo Hyun, et al.
Publicado: (2023)

Total polyp number may be more important than size and histology of polyps for prediction of metachronous high-risk colorectal neoplasms
por: Yoon, Hyuk, et al.
Publicado: (2022)

Gut Microbiome in Probable Intestinal Tuberculosis and Changes following Anti-Tuberculosis Treatment
por: Yoon, Hyuk, et al.
Publicado: (2022)

A double-blind randomized clinical trial of Dracocephalum kotschyi Boiss. in the patients with diarrhea-predominant irritable bowel syndrome
por: Heydari, Parisa, et al.
Publicado: (2022)

Pilot study: a randomised, double blind, placebo controlled trial of pancrealipase for the treatment of postprandial irritable bowel syndrome-diarrhoea
por: Money, Mary E, et al.
Publicado: (2011)

Randomized, placebo-controlled, phase IV pilot study of ramosetron to evaluate the co-primary end points in male patients with irritable bowel syndrome with diarrhea
por: Ida, Motoko, et al.
Publicado: (2017)

Sex-Gender Differences in Irritable Bowel Syndrome
por: Kim, Young Sun, et al.
Publicado: (2018)

Effect of Colostrum on the Symptoms and Mucosal Permeability in Patients with Irritable Bowel Syndrome: A Randomized Placebo-controlled Study
por: Yoon, Jin Young, et al.
Publicado: (2014)

10 years of biologic use patterns in patients with inflammatory bowel disease: treatment persistence, switching and dose intensification – a nationwide population-based study
por: Koo, Hee Moon, et al.
Publicado: (2023)

Efficacy and Safety of Drotaverine Hydrochloride in Irritable Bowel Syndrome: A Randomized Double-Blind Placebo-Controlled Study
por: Rai, Ramesh R., et al.
Publicado: (2014)

Mesalazine Has No Effect on Mucosal Immune Biomarkers in Patients with Diarrhea-Dominant Irritable Bowel Syndrome Referred to Shariati Hospital: A Randomized Double-Blind, Placebo-Controlled Trial
por: Ghadir, Mohammad Reza, et al.
Publicado: (2017)

Comparison of loss of response between anti-tumor necrosis factor alone and combined use with immunomodulators in patients with inflammatory bowel disease
por: Hong, Seung Wook, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_u2tdvrpv7d9qv1i0bua4kcvn3k